Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqCM:ATYR
NasdaqCM:ATYRBiotechs

aTyr Pharma (ATYR): Evaluating Valuation Following New Efzofitimod Data and Securities Lawsuit

aTyr Pharma (ATYR) is drawing attention after presenting fresh Phase 3 results for its lead drug candidate, efzofitimod, at a major medical conference. The company also faces a newly filed securities class action lawsuit. See our latest analysis for aTyr Pharma. After a rocky stretch, aTyr Pharma’s recent ERS Congress presentation sparked renewed attention and contributed to a sharp 36.7% 7-day share price rebound, even as the stock remains down 72.9% this year. While the 1-year total...
TSX:OLY
TSX:OLYCapital Markets

Can Olympia Financial (TSX:OLY) Monthly Dividends Reveal Insights Into Its Long-Term Strategy?

Olympia Financial Group Inc. recently affirmed a monthly dividend of C$0.60 per share, payable on October 31, 2025, with an ex-date and record date of October 22, 2025. This consistent monthly dividend offering highlights the company's ongoing appeal for investors prioritizing regular income from their equity holdings. We’ll explore how Olympia Financial Group’s ongoing monthly dividend remains a central feature of its investment narrative. Uncover the next big thing with financially sound...